Department of Pharmacology, Faculty of Medicine, University of Oslo, Oslo, Norway.
J Mol Cell Cardiol. 2013 Mar;56:129-38. doi: 10.1016/j.yjmcc.2012.11.015. Epub 2012 Dec 7.
Beta-adrenergic receptor (βAR) inotropic effects are attenuated and muscarinic receptor-mediated inhibition thereof is enhanced in heart failure. We investigated if increased G(i) activity contributes to attenuated βAR-inotropic effects and potentiates muscarinic accentuated antagonism in failing rat ventricle. Contractility was measured in ventricular strips and adenylyl cyclase (AC) activity in ventricular membranes from rats with post-infarction heart failure (HF) or Sham-operated controls (Sham). The maximal βAR-mediated inotropic effect of isoproterenol was reduced by 70% and basal, βAR- & forskolin-stimulated AC activity was significantly lower in HF vs. Sham. Carbachol-evoked antagonism of the βAR-mediated inotropic response was complete only in HF despite a ~40% reduction in the ability of carbachol to inhibit βAR-stimulated AC. However, neither the relative efficacy (contractility decreased by ~46%) nor the potency of carbachol to inhibit the βAR inotropic response differed between Sham and HF ventricle. Pertussis toxin (PTX) inactivation of G(i) did not increase the maximal βAR inotropic effect or the attenuated basal, βAR- & forskolin-stimulated AC activity in HF, but increased the potency of isoproterenol only in Sham (0.5 log unit). In HF ventricle pretreated with PTX, simultaneous inhibition of phosphodiesterases 3,4 (PDE3,4) alone produced a larger inotropic response than isoproterenol in ventricle untreated with PTX (84% and 48% above basal respectively). In the absence of PTX, PDE3,4 inhibition evoked negligible inotropic effects in HF. These data are not consistent with the hypothesis that increased G(i) activity contributes to the reduced βAR-mediated inotropic response and AC activity in failing ventricle. The data, however, support the hypothesis that G(i), through chronic receptor independent inhibition of AC, together with PDE3,4 activity, is necessary to maintain a low basal level of contractility.
β肾上腺素能受体(βAR)的变力效应减弱,而迷走神经受体介导的抑制作用增强,这在心力衰竭中可见。我们研究了 G(i) 活性的增加是否有助于减弱βAR 的变力效应,并增强衰竭的大鼠心室中迷走神经增强的拮抗作用。在梗塞后心力衰竭(HF)或假手术对照(Sham)大鼠的心室条和心室膜中测量收缩性和腺苷酸环化酶(AC)活性。异丙肾上腺素介导的最大βAR 变力效应降低了约 70%,HF 中基础、βAR-和 forskolin 刺激的 AC 活性明显低于 Sham。尽管卡巴胆碱抑制βAR 刺激的 AC 的能力降低了约 40%,但卡巴胆碱引起的βAR 介导的变力反应的拮抗作用在 HF 中完全。然而,卡巴胆碱抑制βAR 变力反应的相对效力(收缩力降低约 46%)和效力在 Sham 和 HF 心室之间没有差异。百日咳毒素(PTX)失活 G(i) 并没有增加 HF 中最大的βAR 变力效应或减弱的基础、βAR-和 forskolin 刺激的 AC 活性,但在 Sham 中仅增加了异丙肾上腺素的效力(~0.5 对数单位)。在 HF 心室中用 PTX 预处理后,单独抑制磷酸二酯酶 3,4(PDE3,4)产生的变力反应大于未经 PTX 处理的心室中的异丙肾上腺素(分别比基础水平高 84%和 48%)。在没有 PTX 的情况下,PDE3,4 抑制在 HF 中引起微不足道的变力作用。这些数据与增加的 G(i) 活性有助于减少衰竭心室中βAR 介导的变力反应和 AC 活性的假说不一致。然而,这些数据支持 G(i) 通过慢性受体非依赖性抑制 AC 以及 PDE3,4 活性,对于维持低基础收缩性是必要的假说。